证券代码：002513 证券简称：蓝丰生化 公告编号：2025-024 江苏蓝丰生物化工股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏。 一、特别提示： 1、本次股东大会未出现否决议案的情形。 2、本次股东大会不涉及变更前次股东大会决议。 二、会议召开情况 1、会议召开方式：本次股东大会采用现场投票与网络投票相结合的方式。 2、召开时间 （1）现场会议召开时间为：2025 年 5 月 22 日（星期四）下午 14：00。 （2）网络投票时间为：2025 年 5 月 22 日。其中： 3、现场会议召开地点：安徽省滁州市中新苏滁高新技术产业开发区建业路 1 号旭合科技办公楼 202 会议室。 4、召集人：江苏蓝丰生物化工股份有限公司董事会 5、主持人：董事长郑旭先生 6、股权登记日：2025 年 5 月 19 日（星期一） 7、本次股东大会会议的召集符合有关法律、行政法规、部门规章、规范性 文件和《公司章程》等规定。 三、会议出席情况 1、出席会议的总体情况 1 出席会议的股东（或股东授权委托的代理人）共 95 名，代表 ...

Group 1: Financial Performance and Strategies - The company raised 350 million CNY through a specific issuance of A-shares, currently in the preparation stage for application materials [2] - In Q1 2025, the company reported a loss primarily due to market conditions affecting product prices in both agricultural and photovoltaic sectors, although losses have narrowed compared to the same period last year [5] - The gross profit margins for 2024 are as follows: Agricultural sector at 2.20%, Photovoltaic sector at -4.22%, with specific product margins including pesticide raw materials at 6.98% and battery cells at -3.08% [4] Group 2: Operational Developments - The company has sufficient orders in the photovoltaic sector, with production capacity nearing full utilization [3] - The company is actively developing new energy station projects, aiming to secure key project implementations in 2025 [3] - The average mass production efficiency of TOPCon battery cells is 26.5%, with component power reaching over 720W and efficiency exceeding 23.6% [3] Group 3: Cost Management and Efficiency - Direct material costs account for 65% (approximately 819.55 million CNY) of the photovoltaic business's operating costs and 68% (approximately 385.36 million CNY) for the agricultural business [6] - The company is focusing on cost control and efficiency improvement through enhanced production management, procurement optimization, and market expansion [7] - The company has implemented measures to improve operational efficiency and reduce costs, including advancing product R&D and optimizing market strategies [7] Group 4: Future Outlook and Challenges - The company aims to balance its dual main businesses of agriculture and new energy for sustainable growth [5] - Despite historical challenges, the management is committed to enhancing operational performance and profitability [7] - The company is exploring high-margin sectors for future development while maintaining a focus on cost reduction and efficiency [5]

证券代码：002513 证券简称：蓝丰生化 公告编号：2025-023 江苏蓝丰生物化工股份有限公司 关于举办 2024 年度网上业绩说明会的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记载、 误导性陈述或者重大遗漏。 江苏蓝丰生物化工股份有限公司（以下简称"公司"）已于 2025 年 4 月 29 日在巨潮资讯网上披露了公司《2024 年年度报告》及《2024 年年度报告摘要》。 为便于广大投资者更加全面深入地了解公司经营业绩、发展战略等情况，公 司定于 2025 年 5 月 21 日（星期三）15:00-17:00 在"价值在线"（www.ir- online.cn）举办江苏蓝丰生物化工股份有限公司 2024 年度网上业绩说明会，与 投资者进行沟通和交流，广泛听取投资者的意见和建议。 一、说明会召开的时间、地点和方式 会议召开时间：2025年5月21日（星期三）15:00-17:00 会议召开地点：价值在线（www.ir-online.cn） 会议召开方式：网络互动方式 二、参加人员 参加本次网上说明会的人员有：董事长郑旭先生，董事、总经理李质磊先生， 副总经理、财务总监邢军先生， ...

Market Overview - The Shanghai Composite Index is at 3305.11 points, above the annual line, with an increase of 0.80% [1] - The total trading volume of A-shares is 646.819 billion yuan [1] Stocks Breaking Annual Line - A total of 233 A-shares have surpassed the annual line today [1] - Notable stocks with significant deviation rates include: - Jinkai Biological Science and Technology (10.11%) - Disen Power (9.84%) - Hanbo High-tech (8.84%) [1] Stock Performance Details - The top stocks with their respective performance metrics are as follows: - Jinkai Biological: Price increased by 10.32%, turnover rate 13.55%, latest price 33.02 yuan [1] - Disen Power: Price increased by 10.04%, turnover rate 1.77%, latest price 4.93 yuan [1] - Hanbo High-tech: Price increased by 9.42%, turnover rate 3.54%, latest price 15.33 yuan [1] - Other notable stocks include: - Jiashitang (9.97%, 3.57%, 13.13 yuan) - Sanmu Group (9.94%, 7.78%, 3.54 yuan) [1] Additional Stocks with Minor Deviations - Stocks with smaller deviation rates that have just crossed the annual line include: - Yongqing Environmental Protection - Dongjian Technology - Aishide [1]

Core Viewpoint - The company, Jiangsu Lanfeng Bio-chemical Co., Ltd., reported a net loss of approximately 25.25 million yuan for the year 2024, while its revenue increased by 2.96% to approximately 179.31 million yuan, indicating a challenging operational environment due to industry pressures and competitive pricing in the photovoltaic sector [4][10][30]. Financial Performance - The company achieved a total revenue of 179,314.10 thousand yuan in 2024, marking a 2.96% increase compared to the previous year [4]. - The net profit attributable to shareholders was -25,250.08 thousand yuan, which represents a reduction in losses by 7,975.97 thousand yuan compared to the previous year [4]. - Total assets at the end of the reporting period were 341,883.42 thousand yuan, a 0.57% increase year-on-year, while total liabilities decreased by 1.36% to 310,625.48 thousand yuan [4]. - The equity attributable to shareholders increased by 29.01% to 3,253.69 thousand yuan [4]. Business Segments - The company operates primarily in two segments: agrochemical and photovoltaic new energy [4]. - In the agrochemical sector, the company focuses on the research, production, and sales of efficient, low-toxicity pesticides, fungicides, and herbicides, maintaining its market position despite industry challenges [5]. - In the photovoltaic sector, the company is advancing its N-type TOPCon technology to enhance battery efficiency and expand its market presence, although it faces significant pressure from declining product prices and increased competition [7]. Profit Distribution Plan - The company plans not to distribute cash dividends, issue bonus shares, or increase capital reserves due to negative retained earnings and a net loss for the year [10][12]. - The board believes that this decision aligns with the company's operational performance and future development strategy, ensuring sufficient funds for ongoing operations and projects [10][12]. Audit and Compliance - The company has proposed to reappoint Gongzheng Tianye Accounting Firm as its auditor for the year 2025, following a satisfactory performance in the previous audit [14][26]. - The audit firm has a strong track record and is deemed capable of meeting the company's auditing needs [15][25]. Financing and Guarantees - The company intends to apply for a comprehensive credit limit of up to 3 billion yuan from financial institutions for operational needs, with certain directors providing guarantees without charging fees [31][35]. - This financing strategy is aimed at supporting the company's strategic goals and ensuring operational continuity [36][40].

Core Viewpoint - The dye concept stocks have experienced significant upward movement, with several companies seeing substantial gains in their stock prices [1] Company Performance - United Chemical and Jianxin Co. both surged over 10% in stock price [1] - Bluefeng Biochemical reached the daily limit up [1] - Jihua Group, Yayun Co., and Dinglong Technology all increased by over 5% [1] - Other companies such as Runhe Materials, Runtu Co., Jinjis Co., and Qicai Chemical also saw positive movements in their stock prices [1]

一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.6849 | -0.8911 | 23.14 | -0.8576 | | 每股净资产（元） | 0.09 | 0.07 | 28.57 | 0.96 | | 每股公积金(元) | 5.69 | 5.08 | 12.01 | 5.09 | | 每股未分配利润(元) | -6.54 | -5.88 | -11.22 | -4.99 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 17.93 | 17.42 | 2.93 | 14.45 | | 净利润(亿元) | -2.53 | -3.32 | 23.8 | -3.21 | | 净资产收益率(%) | -237.81 | -173.39 | -37.15 | -55.31 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 10019.62万股 ...

江苏蓝丰生物化工股份有限公司 2024 年度独立董事述职报告 （独立董事-汤健） 本人作为江苏蓝丰生物化工股份有限公司（以下简称"公司"）第七届董事 会独立董事，根据《公司法》《上市公司独立董事规则》等有关法律法规和《公 司章程》的要求，在 2024 年度任职期间，谨慎、勤勉地履行了独立董事的职责， 积极出席公司 2024 年度任职期间召开的相关会议，与公司管理层保持沟通交流， 认真审阅了相关会议文件和议案，并对相关重要事项发表了独立意见，切实维护 了公司和全体股东特别是中小股东的合法权益。现就 2024 年度履行职责情况汇 报如下： 一、独立董事的基本情况 （一）个人履历、专业背景及兼职情况 汤健，中国国籍，1966 年出生，无境外永久居留权，硕士学历。曾任湖南工 商大学会计学院副教授、教授，会计学院会计系副主任，会计学院副院长；现任 湖南工商大学会计学院专职教授，2023 年 7 月至今任江苏蓝丰生物化工股份有 限公司独立董事。 （二）关于独立性的说明 作为公司独立董事，本人及直系亲属、主要社会关系没有在公司及其附属企 业任职，也没有在直接或间接持有公司 5%或 5%以上已发行股份的股东单位任职； 没有为 ...

江苏蓝丰生物化工股份有限公司 2024 年度独立董事述职报告 （二）关于独立性的说明 作为公司独立董事，本人及直系亲属、主要社会关系没有在公司及其附属企 业任职，也没有在直接或间接持有公司 5%或 5%以上已发行股份的股东单位任职； 没有为公司及其附属企业提供财务、法律、管理咨询、技术咨询等有偿服务，也 没有从公司及其主要股东单位或有利害关系的机构取得未予披露的其他利益，不 存在影响独立性的情况。 （独立董事-袁坚） 二、独立董事年度履职情况 本人作为江苏蓝丰生物化工股份有限公司（以下简称"公司"）的独立董事， 根据《公司法》、《上市公司独立董事规则》等有关法律法规和《公司章程》的 要求，在 2024 年度谨慎、勤勉地履行了独立董事的职责，积极出席公司 2024 年 度召开的相关会议，与公司管理层保持沟通交流，认真审阅了相关会议文件和议 案，并对相关重要事项发表了独立意见，切实维护了公司和全体股东特别是中小 股东的合法权益。现就 2024 年度履行职责情况汇报如下： （一）出席股东大会及董事会的情况 一、独立董事的基本情况 （一）个人履历、专业背景及兼职情况 袁坚，中国国籍，1983 年出生，无境外永久居留权 ...

江苏蓝丰生物化工股份有限公司 2025年4月28日 董事会对独立董事独立性自查情况的专项报告 1 依据《上市公司独立董事管理办法》《深圳证券交易所股票上市规则》《深 圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等监管 规则的相关规定，江苏蓝丰生物化工股份有限公司（以下简称"公司"）董事会， 就公司独立董事袁坚先生、刘兴翀先生和汤健女士的独立性情况进行评估并出具 如下专项意见： 公司独立董事袁坚先生、刘兴翀先生和汤健女士符合《上市公司独立董事管 理办法》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范 运作》中对独立董事独立性的相关要求。 江苏蓝丰生物化工股份有限公司董事会 经核查独立董事袁坚先生、刘兴翀先生和汤健女士的任职经历以及签署的相 关文件，上述人员未在公司担任除独立董事以外的任何职务，也未在公司主要股 东公司担任任何职务，与公司以及公司主要股东、实际控制人不存在直接或者间 接利害关系，或其他可能影响其进行独立客观判断的关系。 ...